rs4147857

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000350.3(ABCA4):​c.5814A>G​(p.Leu1938Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 1,613,452 control chromosomes in the GnomAD database, including 29,638 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3167 hom., cov: 31)
Exomes 𝑓: 0.19 ( 26471 hom. )

Consequence

ABCA4
NM_000350.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18O:1

Conservation

PhyloP100: -0.130
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-94008772-T-C is Benign according to our data. Variant chr1-94008772-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 99407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-94008772-T-C is described in Lovd as [Benign]. Variant chr1-94008772-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.236 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA4NM_000350.3 linkc.5814A>G p.Leu1938Leu synonymous_variant Exon 41 of 50 ENST00000370225.4 NP_000341.2 P78363Q6AI28
ABCA4NM_001425324.1 linkc.5592A>G p.Leu1864Leu synonymous_variant Exon 40 of 49 NP_001412253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA4ENST00000370225.4 linkc.5814A>G p.Leu1938Leu synonymous_variant Exon 41 of 50 1 NM_000350.3 ENSP00000359245.3 P78363
ABCA4ENST00000465352.1 linkn.230A>G non_coding_transcript_exon_variant Exon 2 of 6 5

Frequencies

GnomAD3 genomes
AF:
0.201
AC:
30566
AN:
151826
Hom.:
3152
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.240
Gnomad AMI
AF:
0.136
Gnomad AMR
AF:
0.208
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.174
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.192
Gnomad OTH
AF:
0.188
GnomAD3 exomes
AF:
0.190
AC:
47731
AN:
251474
Hom.:
4842
AF XY:
0.184
AC XY:
25043
AN XY:
135910
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.244
Gnomad ASJ exome
AF:
0.205
Gnomad EAS exome
AF:
0.127
Gnomad SAS exome
AF:
0.136
Gnomad FIN exome
AF:
0.177
Gnomad NFE exome
AF:
0.192
Gnomad OTH exome
AF:
0.189
GnomAD4 exome
AF:
0.188
AC:
274047
AN:
1461508
Hom.:
26471
Cov.:
33
AF XY:
0.186
AC XY:
134952
AN XY:
727058
show subpopulations
Gnomad4 AFR exome
AF:
0.248
Gnomad4 AMR exome
AF:
0.241
Gnomad4 ASJ exome
AF:
0.207
Gnomad4 EAS exome
AF:
0.136
Gnomad4 SAS exome
AF:
0.135
Gnomad4 FIN exome
AF:
0.180
Gnomad4 NFE exome
AF:
0.190
Gnomad4 OTH exome
AF:
0.185
GnomAD4 genome
AF:
0.202
AC:
30633
AN:
151944
Hom.:
3167
Cov.:
31
AF XY:
0.199
AC XY:
14746
AN XY:
74260
show subpopulations
Gnomad4 AFR
AF:
0.240
Gnomad4 AMR
AF:
0.208
Gnomad4 ASJ
AF:
0.214
Gnomad4 EAS
AF:
0.131
Gnomad4 SAS
AF:
0.131
Gnomad4 FIN
AF:
0.174
Gnomad4 NFE
AF:
0.192
Gnomad4 OTH
AF:
0.194
Alfa
AF:
0.195
Hom.:
6848
Bravo
AF:
0.208
Asia WGS
AF:
0.161
AC:
561
AN:
3478
EpiCase
AF:
0.190
EpiControl
AF:
0.189

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:18Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 10, 2012
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3Other:1
-
Retina International
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stargardt Disease, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Age related macular degeneration 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

ABCA4-related disorder Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Severe early-childhood-onset retinal dystrophy Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cone-Rod Dystrophy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinitis pigmentosa 19 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cone-rod dystrophy 3 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.4
DANN
Benign
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4147857; hg19: chr1-94474328; COSMIC: COSV64672046; COSMIC: COSV64672046; API